Literature DB >> 30852646

Use of serum citrulline concentrations from routine newborn screen as a biomarker for necrotizing enterocolitis.

Sharmila Babu1, Malavika Prasad2, Malki Miller1, Mark Morrissey3, Alok Bhutada1, Mary Rojas1, Shantanu Rastogi4,5.   

Abstract

PURPOSE: Necrotizing enterocolitis (NEC), a leading cause of mortality and morbidity in preterm neonates, lacks a reliable biomarker. Citrulline is primarily produced by enterocytes and correlates with intestinal function. Serum citrulline concentration (CIT) is routinely measured in routine newborn screening (NBS). The purpose of the study is to test if CIT from NBS may predict the occurrence of NEC and whether it correlates with the time to full feeds (TTFF) and length of stay (LOS), serving as a biomarker of NEC and intestinal health.
METHODS: In a retrospective case control study conducted on neonates with gestational age of 26-32 weeks, we compared CIT levels between cases (neonates with NEC) and controls (next-born neonate). NBS was collected within first 24 h, at day 5 and when the neonates achieved full feeds and were compared using non-parametric tests.
RESULTS: There was no difference in CIT between the controls and cases on day 1 [11.42 (7.42-14.84 vs. 11.93 (6.85-18.8) µmol/L, p = 0.55], on day 5 [11.99 (7.99-16.55) vs. 13.70 (7.42-26.83) µmol/L, p = 0.05], or at full feeds [14.86 (6.85-25.69) vs. 15.7 (7.42-26.26) µmol/L, p = 0.87]. CIT on day 1 did not correlate with TTFF (r = 0.08, p = 0.53) or LOS (r = 0.23, p = 0.06), respectively).
CONCLUSIONS: CIT from routine NBS does not serve as a biomarker to predict NEC in preterm neonates.

Entities:  

Keywords:  Biomarker; Citrulline; Necrotizing enterocolitis; Newborn screen; Tandem mass spectroscopy

Mesh:

Substances:

Year:  2019        PMID: 30852646     DOI: 10.1007/s00383-019-04470-9

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  25 in total

1.  Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome.

Authors:  J Marc Rhoads; Emily Plunkett; Joseph Galanko; Steven Lichtman; Lesli Taylor; Angela Maynor; Timothy Weiner; Katherine Freeman; J Lindhe Guarisco; Guo Yao Wu
Journal:  J Pediatr       Date:  2005-04       Impact factor: 4.406

2.  Reduced serum amino acid concentrations in infants with necrotizing enterocolitis.

Authors:  R M Becker; G Wu; J A Galanko; W Chen; A R Maynor; C L Bose; J M Rhoads
Journal:  J Pediatr       Date:  2000-12       Impact factor: 4.406

3.  Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans.

Authors:  P Crenn; C Coudray-Lucas; F Thuillier; L Cynober; B Messing
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

4.  The value of plasma citrulline to predict mucosal injury in intestinal allografts.

Authors:  G Gondolesi; S Ghirardo; K Raymond; L Hoppenhauer; D Surillo; C Rumbo; T Fishbein; C Sansaricq; B Sauter
Journal:  Am J Transplant       Date:  2006-09-04       Impact factor: 8.086

5.  Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.

Authors:  T H Zytkovicz; E F Fitzgerald; D Marsden; C A Larson; V E Shih; D M Johnson; A W Strauss; A M Comeau; R B Eaton; G F Grady
Journal:  Clin Chem       Date:  2001-11       Impact factor: 8.327

6.  Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease.

Authors:  Pascal Crenn; Kouroche Vahedi; Anne Lavergne-Slove; Luc Cynober; Claude Matuchansky; Bernard Messing
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

7.  Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.

Authors:  Cinzia Papadia; Roy A Sherwood; Chrysostomos Kalantzis; Katharina Wallis; Umberto Volta; Erica Fiorini; Alastair Forbes
Journal:  Am J Gastroenterol       Date:  2007-04-24       Impact factor: 10.864

8.  The citrulline generation test: proposal for a new enterocyte function test.

Authors:  J H C Peters; N J Wierdsma; T Teerlink; P A M van Leeuwen; C J J Mulder; A A van Bodegraven
Journal:  Aliment Pharmacol Ther       Date:  2008-03-10       Impact factor: 8.171

Review 9.  Arginine metabolism and nutrition in growth, health and disease.

Authors:  Guoyao Wu; Fuller W Bazer; Teresa A Davis; Sung Woo Kim; Peng Li; J Marc Rhoads; M Carey Satterfield; Stephen B Smith; Thomas E Spencer; Yulong Yin
Journal:  Amino Acids       Date:  2008-11-23       Impact factor: 3.520

10.  Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome.

Authors:  Céline Bailly-Botuha; Virginie Colomb; Elizabeth Thioulouse; Marie-Clotilde Berthe; Karine Garcette; Béatrice Dubern; Olivier Goulet; Rémy Couderc; Jean-Philippe Girardet
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.